1. Peters M.J., Symmons D.P., McCarey D.W. et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other types of inflammatory arthritis — TASK FORCE «Cardiovascular risk management in RA». Ann Rheum Dis 2010;69:325–31.Poole C.D., Conway P., Currie C.J. An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice. Rheumatology (Oxford) 2009;48:78–82.
2. Rho Y.H., Chung C.P., Oeser A, et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009;15;61:1580–5.
3. López-Longo F.J., Oliver-Miñarro D., de la Torre I. et al. Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis. Arthritis Rheum 2009;61:419–24.
4. Novikova D.S., Popkova T.V., Mach E.S., Nasonov E.L. Stiff arteries — an integral indicator of cardiovascular risk in patients with rheumatoid arthritis. Nauchno-Prakticheskaya Revmatologiya 2009; (5):38–48. Russian (Новикова Д.С., Попкова Т.В., Мач Э.С., Насонов Е.Л. Ригидность артерий — интегральный показатель сердечно-сосудистого риска у больных ревматоидным артритом. Научно-Практическая Ревматология 2009; (5):38–48).
5. Millasseau S.C., Kelly R.P., Ritter J.M., Chowienczyk P.J. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond) 2002;103(4):371–7.
6. Millasseaua S.C., Ritter J.M., Takazawab K., Chowienczyka P.J. Contour analysis of the photoplethysmographic pulse measured at the finger. J Hypertens 2006;24:1449–56.
7. Dawber T.R., Thomas H.E., McNamara P.M. Characteristics of the dicrotic notch of the arterial pulse wave in coronary heart disease. Angiology 1973;24:244–255.
8. Arnett F.C., Edworthy S.M., Bloch D.A. The ARA 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
9. Olyunin Yu.A. Assessment activity and the effectiveness of therapy of rheumatoid arthritis. International indices of activity assessment, functional status and quality of life of patients with rheumatic diseases. Moscow: Russian Association of Rheumatology; 2007. Russian (Олюнин Ю.А. Оценка активности и эффективности терапии ревматоидного артрита. Международные индексы оценки активности, функционального статуса и качества жизни больных ревматическими заболеваниями. М.: Ассоциация ревматологов России; 2007).
10. Nasonov E.L., editor. Rheumatology. Clinical recommendations. Moscow: GEOTAR-Media; 2010. Russian (Насонов Е.Л., редактор. Ревматология. Клинические рекомендации. М.: ГЭОТАР-Медиа; 2010).
11. De Backer G., Ambrosioni E., Borch-Johnsen K. et al. Third Joint Force of European and other Societies on Cardiovascular Disease and Prevention in Clinical Practice. European guidelines on cardiovascular disease and prevention in clinical practice. Atherosclerosis 2003;171:145–55.
12. Haward G., Sharrett A.R., Heiss G. et al. Carotid artery intima-media thickness distribution in general populations as evaluated by B-mode ultrasound. Stroke 1993;24:1297–1304.
13. National guidelines for diagnosis and treatment of hypertension (4th revision). Sistemye Gipertenzii 2010; (3):5–26. Russian (Национальные рекомендации по диагностике и лечению артериальной гипертонии (четвертый пересмотр). Системные гипертензии 2010; (3): 5–26).
14. National guidelines for diagnosis and treatment of chronic heart failure. Serdechnaya Nedostatochnost' 2010;11(1): 1–45. Russian (Национальные рекомендации по диагностике и лечению хронической сердечной недостаточности. Сердечная недостаточность 2010;11(1): 1–45).
15. Gerasimov A.N., Shpitonkov M.I. Comparative analysis of the autocorrelation function and the scope for some epidemiological problems. Trudy Instituta Sistemnogo Analiza RAN 2008;32(1): 290–4. Russian (Герасимов А.Н., Шпитонков М.И. Сравнительный анализ автокорреляционной функции и размаха для некоторых эпидемиологических задач. Труды Института Системного анализа РАН 2008;32(1): 290–4.
16. Guidelines for immunologic laboratory testing in the rheumatic diseases: an introduction. American college of rheumatology ad hoc committee on immunologic testing guidelines. Arthritis Rheum 2002;47:429–33.
17. Laurent S., Cockcroft J., Van Bortel L. et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications European Heart Journal 2006;27:2588–605.
18. Gunarathne A., Patel J.V., Hughes E.A., Lip G.Y. Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification. Am J Hypertens 2008;21(8):866–72.
19. McEniery C.M., Yasmin, Hall I.R., Quasem A. et al. Normal vascular aging: differential effect on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff Collaborative Trial (ACCT) JACC 2005;46:1753–60.
20. Ryabikov A.N., Malyutina S.K., Ivanov S.V. Vascular stiffness and pulse wave reflection: the relationship with the established and discussed the determinants of cardiovascular disease. In: New evaluation of arterial stiffness — early marker of cardiovascular disease. Symp. XIV Russian National Congress "Man and medicine." Moscow. April 19, 2007 Moscow: Russkiy vrach; 2007: 15–30. Russian (Рябиков А.Н., Малютина С.К., Иванов С.В. Жесткость сосудистой стенки и отражение пульсовой волны: связь с установленными и обсуждаемыми детерминантами сердечно-сосудистых заболеваний. В: Новые возможности оценки артериальной ригидности — раннего маркера развития сердечно-сосудистых заболеваний. Материалы симпозиума. XIV Российский национальный конгресс «Человек и лекарство». Москва. 19 апреля 2007 г. Москва: Русский врач; 2007: 15–30).
21. Park S., Lakatta E.G. Role of inflammation in the pathogenesis of arterial stiffness. Yonsei Med J 2012;53(2):258–61.
22. Potter C., Hyrich K.L., Tracey A. et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis. Ann Rheum Dis 2009;68(1):69–74.
23. Gerli R., BartoloniBocci E., Sherer Y. et al. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann. Rheum Dis 2008;67:724–725.
24. Giles J.T., Malayeri A.A., Fernandes V. et al. Left ventricular structure and function in patients with rheumatoid arthritis, as assessed by cardiac magnetic resonance imaging. Arthr Rheum 2010;62(4):940–51.
25. Van Popele N.M., Grobbee D.E., Bots M. et al. Association between arterial stiffness and atherosclerosis. Stroke 2001;32:454–60.
26. Chen J.Y., Tsai W.C., Lin C.C. et al. Stiffness index derived from digital volume pulse as a marker of target organ damage in untreated hypertension. Blood Press 2005;14(4):233–7.